Correlation Between Pasithea Therapeutics and Pulmatrix
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Pulmatrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Pulmatrix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Pulmatrix, you can compare the effects of market volatilities on Pasithea Therapeutics and Pulmatrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Pulmatrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Pulmatrix.
Diversification Opportunities for Pasithea Therapeutics and Pulmatrix
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Pasithea and Pulmatrix is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Pulmatrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmatrix and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Pulmatrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmatrix has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Pulmatrix go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Pulmatrix
Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 28.0 times more return on investment than Pulmatrix. However, Pasithea Therapeutics is 28.0 times more volatile than Pulmatrix. It trades about 0.17 of its potential returns per unit of risk. Pulmatrix is currently generating about 0.05 per unit of risk. If you would invest 4.99 in Pasithea Therapeutics Corp on November 2, 2024 and sell it today you would lose (2.48) from holding Pasithea Therapeutics Corp or give up 49.7% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 50.2% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. Pulmatrix
Performance |
| Timeline |
| Pasithea Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
OK
| Pulmatrix |
Pasithea Therapeutics and Pulmatrix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and Pulmatrix
The main advantage of trading using opposite Pasithea Therapeutics and Pulmatrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Pulmatrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will offset losses from the drop in Pulmatrix's long position.The idea behind Pasithea Therapeutics Corp and Pulmatrix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Pulmatrix vs. Capricor Therapeutics | Pulmatrix vs. Akari Therapeutics PLC | Pulmatrix vs. Soleno Therapeutics | Pulmatrix vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |